Clinical Services

HORMONE REPLACEMENT THERAPY

HORMONE REPLACEMENT THERAPY

NOTES

Ascertain which hormone was used and the underlying condition, it is important to exclude hormones for tumour chemotherapy

ACCEPT:

  • If HRT is prescribed for menopausal symptoms
  • If HRT is prescribed for osteoporosis prevention
  • If treated with growth hormone that was exclusively recombinant
  • If treatment is for a shortage of sex hormones, e.g. in some cases of erectile dysfunction
  • 3 months after last dose of CLOMID if donor is not pregnant

 DEFER:

  • If hormone therapy/treatment is being used as part of infertility treatment

PERMANENTLY EXCLUDE:

  • If donor has received Human Gonadotropin of pituitary origin
  • If donor received human pituitary growth hormone
  • If hormone therapy has been prescribed for any malignancy e.g. tumour chemotherapy

SEE IF RELEVANT

 

ADDITIONAL INFORMATION

There are many reasons why an individual may be deficient in a specific hormone. If this is related directly to malignancy, or to the treatment of malignancy, or to the use of pituitary derived hormones (these have been linked with prion associated diseases), the donor cannot donate in order to protect any person who may receive a donation from that individual. If there is a risk to the safety of the donor, as may be the case with a deficiency of adrenal steroid hormones, then the donor must be deferred

 

IBTS/MEDD/DSGDE/0001Attachment 4.238Ver 1.1

 

 

 

Sign up to Our Newsletter

Sign up to Our Newsletter

loading form...